Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis
- PMID: 8431208
- DOI: 10.1002/art.1780360209
Temporal covariation of soluble interleukin-2 receptor levels, daily stress, and disease activity in rheumatoid arthritis
Abstract
Objective: To examine synchronous changes in soluble interleukin-2 receptor (sIL-2R) levels, daily indicators of emotional stress, joint inflammation, and reported pain in patients with rheumatoid arthritis (RA).
Methods: Fourteen patients were studied on each of 6 occasions, 2 weeks apart. Measures included daily ratings of mood disturbance, undesirable events, and joint pain; clinical examination of joint swelling; and serum assays of sIL-2R. Pooled within-person correlations among these variables were calculated.
Results: Consistent with the results of previous research, joint inflammation covaried directly with sIL-2R levels. Changes in mood disturbance were unrelated to changes in joint inflammation, but increases in mood disturbance were linked with decreases in sIL-2R levels and increases in reported joint pain.
Conclusion: These findings provide preliminary evidence that psychoimmune processes may be implicated in short-term changes in RA disease activity.
Similar articles
-
A dual pathway model of daily stressor effects on rheumatoid arthritis.Ann Behav Med. 1997 Spring;19(2):161-70. doi: 10.1007/BF02883333. Ann Behav Med. 1997. PMID: 9603691
-
Soluble interleukin-2 receptor in sera and synovial fluids of rheumatoid patients: correlations with disease activity.Rheumatol Int. 1994;14(2):47-52. doi: 10.1007/BF00300246. Rheumatol Int. 1994. PMID: 7824835
-
Serial levels of soluble interleukin 2 receptor in the peripheral blood of patients with rheumatoid arthritis: correlations with disease activity.J Rheumatol. 1990 May;17(5):597-602. J Rheumatol. 1990. PMID: 2359067
-
Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.Arthritis Rheum. 1994 Jan;37(1):50-6. doi: 10.1002/art.1780370108. Arthritis Rheum. 1994. PMID: 8129764 Clinical Trial.
-
On the role of sIL-2R measurements in rheumatoid arthritis and cancers.Mediators Inflamm. 2005 Aug 14;2005(3):121-30. doi: 10.1155/MI.2005.121. Mediators Inflamm. 2005. PMID: 16106097 Free PMC article. Review.
Cited by
-
Experimental stress in inflammatory rheumatic diseases: a review of psychophysiological stress responses.Arthritis Res Ther. 2010;12(3):R89. doi: 10.1186/ar3016. Epub 2010 May 17. Arthritis Res Ther. 2010. PMID: 20478029 Free PMC article. Review.
-
Regulation of apoptosis in immune cells.J Clin Immunol. 1995 Jan;15(1):1-16. doi: 10.1007/BF01489485. J Clin Immunol. 1995. PMID: 7539010 Review. No abstract available.
-
Neural immune pathways and their connection to inflammatory diseases.Arthritis Res Ther. 2003;5(6):251-65. doi: 10.1186/ar1002. Epub 2003 Sep 23. Arthritis Res Ther. 2003. PMID: 14680500 Free PMC article. Review.
-
Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.Clin Rheumatol. 1995 Jul;14(4):458-63. doi: 10.1007/BF02207682. Clin Rheumatol. 1995. PMID: 7586985 Clinical Trial.
-
Balneotherapy in medicine: A review.Environ Health Prev Med. 2005 Jul;10(4):171-9. doi: 10.1007/BF02897707. Environ Health Prev Med. 2005. PMID: 21432136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical